Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges; ichroma-50, an automated immunoassay system with high-throughput; Hemochroma PLUS, a handheld device that can run tests for anemia; portable analyzers ichroma M3 and ichroma M2; and NuActor, an automated nucleic acid extraction system. It also provides compact immunoassay analyzers, including AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10; cardiac reagents; cancer reagents; COVID-19 reagents; diagnostic reagents; reagents for hormones, infections, autoimmune, organ functions, molecular diagnostics, therapeutic drug monitoring, and other test items. In addition, the company offers Ichroma TRIAS, ultra-high sensitivity respiratory disease diagnostic equipment; ALFIAS-3, a diagnostic equipment; and SyncNeb. Boditech Med Inc. was founded in 1998 and is headquartered in Chuncheon-si, South Korea.
तुलना करने के लिए मीट्रिक्स | 206640 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध206640पीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 13.8x | 9.4x | −0.6x | |
PEG अनुपात | 2.48 | −0.24 | 0.00 | |
क़ीमत/बुक | 1.8x | 0.8x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 2.7x | 1.4x | 3.1x | |
अपसाइड (विश्लेषक लक्ष्य) | 42.8% | 48.3% | 55.1% | |
उचित मूल्य अपसाइड | अनलॉक करें | 29.5% | 9.2% | अनलॉक करें |